Table 1.
Ventilatory and cardiovascular measures for peripheral and central chemoreflex sensitivity in supine position
Central Chemoreflex |
Peripheral Chemoreflex |
|||||||
---|---|---|---|---|---|---|---|---|
Eucapneic normoxia |
Hyperoxic hypercapnia |
Eucapneic hyperoxia |
Eucapneic hypoxia |
|||||
Supine | Controls | POTS | Controls | POTS | Controls | POTS | Controls | POTS |
Arterial oxygen saturation, % | 97.5 ± 0.6 | 97.2 ± 0.2 | 99.2 ± 0.6 | 98.9 ± 0.2 | 99.2 ± 0.6 | 98.9 ± 0.2 | 80.8 ± 2.3* | 84.7 ± 1.4*† |
Minute ventilation, l/min | 4.1 ± 0.4 | 5.5 ± 0.4 | 20.1 ± 2.4* | 14.3 ± 2.1* | 6.1 ± 0.9* | 6.8 ± 0.6* | 6.5 ± 0.6* | 7.5 ± 1.0* |
Respiratory rate, beats/min | 16.7 ± 1.1 | 16.8 ± 0.7 | 15 ± 1.0 | 14.8 ± 0.8 | 18.6 ± 1.0 | 16.9 ± 0.9 | 14.3 ± 0.9 | 16.9 ± 1.0 |
ETCO2, Torr | 43.0 ± 0.7 | 42.2 ± 1.0 | 57.3 ± 4.7* | 55.3 ± 6.6* | 44.3 ± 1.6 | 42.2 ± 1.1 | 43.2 ± 0.8 | 42.3 ± 2.0 |
Heart rate, beats/min | 63.7 ± 3.2 | 75.4 ± 3.2 | 76.5 ± 3.4* | 84.5 ± 3.1* | 60.1 ± 2.7 | 72.8 ± 3.7 | 71.6 ± 3.4 | 83.5 ± 3.2* |
Systolic arterial pressure, mmHg | 121.2 ± 2.8 | 112.7 ± 1.9† | 129.6 ± 4.2 | 125.25 ± 2.7 | 117.7 ± 3.1 | 120.3 ± 2.3 | 116.6 ± 3.1 | 116.9 ± 1.9 |
Diastolic arterial pressure, mmHg | 62.9 ± 1.7 | 61.7 ± 1.6 | 70.3 ± 2.1* | 67.9 ± 1.9 | 62.2 ± 1.9 | 66.2 ± 2.0 | 61.4 ± 2.3 | 64.0 ± 2.2 |
Mean arterial pressure, mmHg | 84.0 ± 1.9 | 79.0 ± 1.5 | 93.6 ± 2.5* | 88.3 ± 1.9 | 83.4 ± 2.4 | 84.1 ± 1.7 | 81.8 ± 2.6 | 84.2 ± 1.9 |
Cardiac output, l/min | 4.9 ± 0.4 | 4.9 ± 0.2 | 6.2 ± 0.3* | 5.6 ± 0.3 | 5.3 ± 0.4 | 4.8 ± 0.3 | 5.8 ± 0.5 | 5.2 ± 0.3 |
TPR, mmHg·l−1·min−1 | 17.9 ± 1.3 | 16.6 ± 1.1 | 16.2 ± 1.1 | 18.2 ± 1.1 | 16.3 ± 1.1 | 18.3 ± 1.1 | 14.8 ± 1.1 | 17.5 ± 1.1 |
Stroke volume, ml | 81.1 ± 8.1 | 66.1 ± 2.1† | 81.1 ± 5.1 | 68.1 ± 3.1 | 93.1 ± 8.1* | 69.1 ± 5.1 | 88.1 ± 11.1 | 66.1 ± 2.1† |
Values are means ± SE.
POTS, postural tachycardia syndrome; ETCO2, end-tidal CO2; TPR, total peripheral resistance.
P < 0.05 compared with eucapneic normoxia;
P < 0.05 compared with controls.